Related references
Note: Only part of the references are listed.Treatment with minocycline after disease onset alters astrocyte reactivity and increases microgliosis in SOD1 mutant mice
A. Florence Keller et al.
EXPERIMENTAL NEUROLOGY (2011)
The unfolded protein response in familial amyotrophic lateral sclerosis
Lijun Wang et al.
HUMAN MOLECULAR GENETICS (2011)
Astrocyte loss of mutant SOD1 delays ALS disease onset and progression in G85R transgenic mice
Lijun Wang et al.
HUMAN MOLECULAR GENETICS (2011)
Dysregulation of the ALS-associated gene TDP-43 leads to neuronal death and degeneration in mice
Lionel M. Igaz et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Abnormal exocytotic release of glutamate in a mouse model of amyotrophic lateral sclerosis
Marco Milanese et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Monitoring systemic oxidative stress in an animal model of amyotrophic lateral sclerosis
Francisco Javier Miana-Mena et al.
JOURNAL OF NEUROLOGY (2011)
Both cytoplasmic and nuclear accumulations of the protein are neurotoxic in Drosophila models of TDP-43 proteinopathies
Laetitia Miguel et al.
NEUROBIOLOGY OF DISEASE (2011)
TDP-43-Based Animal Models of Neurodegeneration: New Insights into ALS Pathology and Pathophysiology
Iga Wegorzewska et al.
NEURODEGENERATIVE DISEASES (2011)
Prion-like propagation of mutant superoxide dismutase-1 misfolding in neuronal cells
Christian Muench et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Loss of murine TDP-43 disrupts motor function and plays an essential role in embryogenesis
Brian C. Kraemer et al.
ACTA NEUROPATHOLOGICA (2010)
Intrinsic properties of lumbar motor neurones in the adult G127insTGGG superoxide dismutase-1 mutant mouse in vivo: evidence for increased persistent inward currents
C. F. Meehan et al.
ACTA PHYSIOLOGICA (2010)
Toward more efficient clinical trials for amyotrophic lateral sclerosis
Merit E. Cudkowicz et al.
AMYOTROPHIC LATERAL SCLEROSIS (2010)
Aggregation modulating elements in mutant human superoxide dismutase 1
Celeste M. Karch et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2010)
Ultrastructural diversity of inclusions and aggregations in the lumbar spinal cord of SOD1-G93A transgenic mice
Yansu Guo et al.
BRAIN RESEARCH (2010)
A genetic model of amyotrophic lateral sclerosis in zebrafish displays phenotypic hallmarks of motoneuron disease
Tennore Ramesh et al.
DISEASE MODELS & MECHANISMS (2010)
Knockdown of transactive response DNA-binding protein (TDP-43) downregulates histone deacetylase 6
Fabienne C. Fiesel et al.
EMBO JOURNAL (2010)
Decreased GLT-1 and increased SOD1 and HO-1 expression in astrocytes contribute to lumbar spinal cord vulnerability of SOD1-G93A transgenic mice
Yansu Guo et al.
FEBS LETTERS (2010)
Oxidative stress in ALS: Key role in motor neuron injury and therapeutic target
Sian C. Barber et al.
FREE RADICAL BIOLOGY AND MEDICINE (2010)
Dismutase-competent SOD1 mutant accumulation in myelinating Schwann cells is not detrimental to normal or transgenic ALS model mice
Bradley J. Turner et al.
HUMAN MOLECULAR GENETICS (2010)
Gain and loss of function of ALS-related mutations of TARDBP (TDP-43) cause motor deficits in vivo
Edor Kabashi et al.
HUMAN MOLECULAR GENETICS (2010)
Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic mice
Margaret Wong et al.
HUMAN MOLECULAR GENETICS (2010)
Neurotoxic effects of TDP-43 overexpression in C-elegans
Peter E. A. Ash et al.
HUMAN MOLECULAR GENETICS (2010)
An examination of wild-type SOD1 in modulating the toxicity and aggregation of ALS-associated mutant SOD1
Mercedes Prudencio et al.
HUMAN MOLECULAR GENETICS (2010)
Glutaredoxin 2 prevents aggregation of mutant SOD1 in mitochondria and abolishes its toxicity
Alberto Ferri et al.
HUMAN MOLECULAR GENETICS (2010)
Hyperactive Intracellular Calcium Signaling Associated with Localized Mitochondrial Defects in Skeletal Muscle of an Animal Model of Amyotrophic Lateral Sclerosis
Jingsong Zhou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
TDP-43 Is a Developmentally Regulated Protein Essential for Early Embryonic Development
Chantelle F. Sephton et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Ubiquilin Modifies TDP-43 Toxicity in a Drosophila Model of Amyotrophic Lateral Sclerosis (ALS)
Keith A. Hanson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Blocking the mitochondrial apoptotic pathway preserves motor neuron viability and function in a mouse model of amyotrophic lateral sclerosis
Nichole A. Reyes et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Elevated expression of TDP-43 in the forebrain of mice is sufficient to cause neurological and pathological phenotypes mimicking FTLD-U
Kuen-Jer Tsai et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Neuronal over-expression of chromogranin A accelerates disease onset in a mouse model of ALS
Samer Abou Ezzi et al.
JOURNAL OF NEUROCHEMISTRY (2010)
Bee venom attenuates neuroinflammatory events and extends survival in amyotrophic lateral sclerosis models
Eun Jin Yang et al.
JOURNAL OF NEUROINFLAMMATION (2010)
Induction of Protective Immunity by Vaccination With Wild-Type Apo Superoxide Dismutase 1 in Mutant SOD1 Transgenic Mice
Shigeko Takeuchi et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2010)
Phosphorylation Promotes Neurotoxicity in a Caenorhabditis elegans Model of TDP-43 Proteinopathy
Nicole F. Liachko et al.
JOURNAL OF NEUROSCIENCE (2010)
Wild-Type Human TDP-43 Expression Causes TDP-43 Phosphorylation, Mitochondrial Aggregation, Motor Deficits, and Early Mortality in Transgenic Mice
Ya-Fei Xu et al.
JOURNAL OF NEUROSCIENCE (2010)
Dorfin Ameliorates Phenotypes in a Transgenic Mouse Model of Amyotrophic Lateral Sclerosis
Jun Sone et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2010)
Methionine sulfoximine, an inhibitor of glutamine synthetase, lowers brain glutamine and glutamate in a mouse model of ALS
Farhad Ghoddoussi et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2010)
The evidence for altered RNA metabolism in amyotrophic lateral sclerosis (ALS)
Michael J. Strong
JOURNAL OF THE NEUROLOGICAL SCIENCES (2010)
Dynamic NAD(P)H post-synaptic autofluorescence signals for the assessment of mitochondrial function in a neurodegenerative disease: Monitoring the primary motor cortex of G93A mice, an amyotrophic lateral sclerosis model
Stefano Loizzo et al.
MITOCHONDRION (2010)
Mitochondrial fission/fusion dynamics and apoptosis
Clare Sheridan et al.
MITOCHONDRION (2010)
Safety and efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial
Swati P. Aggarwal et al.
LANCET NEUROLOGY (2010)
EXCITABILITY PROPERTIES OF MOUSE MOTOR AXONS IN THE MUTANT SOD1G93A MODEL OF AMYOTROPHIC LATERAL SCLEROSIS
Delphine Boerio et al.
MUSCLE & NERVE (2010)
Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS
Andrew C. Elden et al.
NATURE (2010)
Mutations of optineurin in amyotrophic lateral sclerosis
Hirofumi Maruyama et al.
NATURE (2010)
From transcriptome analysis to therapeutic anti-CD40L treatment in the SOD1 model of amyotrophic lateral sclerosis
John M. Lincecum et al.
NATURE GENETICS (2010)
Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS
Daryl A. Bosco et al.
NATURE NEUROSCIENCE (2010)
Mitochondrial dysfunction and intracellular calcium dysregulation in ALS
Hibiki Kawamata et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2010)
Progressive motor weakness in transgenic mice expressing human TDP-43
Nancy R. Stallings et al.
NEUROBIOLOGY OF DISEASE (2010)
Reduced VGLUT2 expression increases motor neuron viability in Sod1(G93A) mice
Hanna Wootz et al.
NEUROBIOLOGY OF DISEASE (2010)
Lithium carbonate in amyotrophic lateral sclerosis Lack of efficacy in a dose-finding trial
A. Chio et al.
NEUROLOGY (2010)
Misfolded Mutant SOD1 Directly Inhibits VDAC1 Conductance in a Mouse Model of Inherited ALS
Adrian Israelson et al.
NEURON (2010)
Exome Sequencing Reveals VCP Mutations as a Cause of Familial ALS
Jane O. Johnson et al.
NEURON (2010)
Superoxide Dismutase 1 and tgSOD1G93A Mouse Spinal Cord Seed Fibrils, Suggesting a Propagative Cell Death Mechanism in Amyotrophic Lateral Sclerosis
Ruth Chia et al.
PLOS ONE (2010)
TDP-43-Mediated Neuron Loss In Vivo Requires RNA-Binding Activity
Aaron Voigt et al.
PLOS ONE (2010)
Progranulin is Neurotrophic In Vivo and Protects against a Mutant TDP-43 Induced Axonopathy
Angela S. Laird et al.
PLOS ONE (2010)
ALS-linked mutant superoxide dismutase 1 (SOD1) alters mitochondrial protein composition and decreases protein import
Quan Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
A Drosophila model for TDP-43 proteinopathy
Yan Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Deletion of TDP-43 down-regulates Tbc1d1, a gene linked to obesity, and alters body fat metabolism
Po-Min Chiang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Deficits in axonal transport precede ALS symptoms in vivo
Lynsey G. Bilsland et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Altered distributions of Gemini of coiled bodies and mitochondria in motor neurons of TDP-43 transgenic mice
Xiu Shan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration
Hans Wils et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Canine Degenerative Myelopathy
Joan R. Coates et al.
VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE (2010)
Transgenic Rat Model of Neurodegeneration Caused by Mutation in the TDP Gene
Hongxia Zhou et al.
PLOS GENETICS (2010)
Phase 2 study of sodium phenylbutyrate in ALS
Merit E. Cudkowicz et al.
AMYOTROPHIC LATERAL SCLEROSIS (2009)
Randomized Sequential Trial of Valproic Acid in Amyotrophic Lateral Sclerosis
Sanne Piepers et al.
ANNALS OF NEUROLOGY (2009)
A Role for Copper in the Toxicity of Zinc-Deficient Superoxide Dismutase to Motor Neurons in Amyotrophic Lateral Sclerosis
Kari A. Trumbull et al.
ANTIOXIDANTS & REDOX SIGNALING (2009)
Axonal Mitochondrial Clusters Containing Mutant SOD1 in Transgenic Models of ALS
Jose R. Sotelo-Silveira et al.
ANTIOXIDANTS & REDOX SIGNALING (2009)
Intra-bone marrow-bone marrow transplantation slows disease progression and prolongs survival in G93A mutant SOD1 transgenic mice, an animal model mouse for amyotrophic lateral sclerosis
Shizuo Ohnishi et al.
BRAIN RESEARCH (2009)
Tar DNA binding protein of 43 kDa (TDP-43), 14-3-3 proteins and copper/zinc superoxide dismutase (SOD1) interact to modulate NFL mRNA stability. Implications for altered RNA processing in amyotrophic lateral sclerosis (ALS)
Kathryn Volkening et al.
BRAIN RESEARCH (2009)
Vascular Endothelial Growth Factor Prevents G93A-SOD1-Induced Motor Neuron Degeneration
J. Simon Lunn et al.
DEVELOPMENTAL NEUROBIOLOGY (2009)
Sensory involvement in the SOD1-G93A mouse model of amyotrophic lateral sclerosis
Yan-Su Guo et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2009)
Mechano-growth factor, an IGF-I splice variant, rescues motoneurons and improves muscle function in SOD1G93A mice
Joanna Riddoch-Contreras et al.
EXPERIMENTAL NEUROLOGY (2009)
Lenalidomide (Revlimid®) administration at symptom onset is neuroprotective in a mouse model of amyotrophic lateral sclerosis
Arie Neymotin et al.
EXPERIMENTAL NEUROLOGY (2009)
Depletion of TDP-43 affects Drosophila motoneurons terminal synapsis and locomotive behavior
Fabian Feiguin et al.
FEBS LETTERS (2009)
Variants of the elongator protein 3 (ELP3) gene are associated with motor neuron degeneration
Claire L. Simpson et al.
HUMAN MOLECULAR GENETICS (2009)
Wild-type SOD1 overexpression accelerates disease onset of a G85R SOD1 mouse
Lijun Wang et al.
HUMAN MOLECULAR GENETICS (2009)
Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond
Hristelina Ilieva et al.
JOURNAL OF CELL BIOLOGY (2009)
Early Excitability Changes in Lumbar Motoneurons of Transgenic SOD1G85R and SOD1G93A-Low Mice
Arnaud Pambo-Pambo et al.
JOURNAL OF NEUROPHYSIOLOGY (2009)
Progressive Changes in Synaptic Inputs to Motoneurons in Adult Sacral Spinal Cord of a Mouse Model of Amyotrophic Lateral Sclerosis
Mingchen Jiang et al.
JOURNAL OF NEUROSCIENCE (2009)
A Switch in Retrograde Signaling from Survival to Stress in Rapid-Onset Neurodegeneration
Eran Perlson et al.
JOURNAL OF NEUROSCIENCE (2009)
Changes in the Spinal Cord Proteome of an Amyotrophic Lateral Sclerosis Murine Model Determined by Differential In-gel Electrophoresis
Daniel Bergemalm et al.
MOLECULAR & CELLULAR PROTEOMICS (2009)
Cu/Zn Superoxide Dismutase Typical for Familial Amyotrophic Lateral Sclerosis Increases the Vulnerability of Mitochondria and Perturbs Ca2+ Homeostasis in SOD1G93A Mice
Manoj Kumar Jaiswal et al.
MOLECULAR PHARMACOLOGY (2009)
Schwann cells expressing dismutase active mutant SOD1 unexpectedly slow disease progression in ALS mice
Christian S. Lobsiger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration
Iga Wegorzewska et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Genome-wide association analysis reveals a SOD1 mutation in canine degenerative myelopathy that resembles amyotrophic lateral sclerosis
Tomoyuki Awano et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6
Caroline Vance et al.
SCIENCE (2009)
Mutations in the FUS/TLS Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis
T. J. Kwiatkowski et al.
SCIENCE (2009)
Multiple roles of HDAC inhibition in neurodegenerative conditions
De-Maw Chuang et al.
TRENDS IN NEUROSCIENCES (2009)
Frontotemporal dementia and amyotrophic lateral sclerosis-associated disease protein TDP-43 promotes dendritic branching
Yubing Lu et al.
MOLECULAR BRAIN (2009)
An ALS-Linked Mutant SOD1 Produces a Locomotor Defect Associated with Aggregation and Synaptic Dysfunction When Expressed in Neurons of Caenorhabditis elegans
Jiou Wang et al.
PLOS GENETICS (2009)
Destabilizing Protein Polymorphisms in the Genetic Background Direct Phenotypic Expression of Mutant SOD1 Toxicity
Tali Gidalevitz et al.
PLOS GENETICS (2009)
A systematic review of antioxidant treatment for amyotrophic lateral sclerosis/motor neuron disease
Richard W. Orrell et al.
AMYOTROPHIC LATERAL SCLEROSIS (2008)
Design, power, and interpretation of studies in the standard murine model of ALS
Sean Scott et al.
AMYOTROPHIC LATERAL SCLEROSIS (2008)
TDP-43 mutation in familial amyotrophic lateral sclerosis
Akio Yokoseki et al.
ANNALS OF NEUROLOGY (2008)
The prostaglandin E2 EP2 receptor accelerates disease progression and inflammation in a model of amyotrophic lateral sclerosis
Xibin Liang et al.
ANNALS OF NEUROLOGY (2008)
TDP-43 A315T mutation in familial motor neuron disease
Michael A. Gitcho et al.
ANNALS OF NEUROLOGY (2008)
Role of axonal transport in neurodegenerative diseases
Kurt J. De Vos et al.
ANNUAL REVIEW OF NEUROSCIENCE (2008)
Granulocyte-colony stimulating factor improves outcome in a mouse model of amyotrophic lateral sclerosis
Claudia Pitzer et al.
BRAIN (2008)
Skeletal Muscle Is a Primary Target of SOD1G93A-Mediated Toxicity
Gabriella Dobrowolny et al.
CELL METABOLISM (2008)
Non-Cell-Autonomous Effect of Human SOD1G37R Astrocytes on Motor Neurons Derived from Human Embryonic Stem Cells
Maria C. N. Marchetto et al.
CELL STEM CELL (2008)
KNS-760704 [(6R)-4,5,6,7-tetrahydro-N6-propyl-2, 6-benzothiazole-diamine dihydrochloride monohydrate] for the treatment of amyotrophic lateral sclerosis
Valentin K. Gribkoff et al.
CNS NEUROSCIENCE & THERAPEUTICS (2008)
GABAA receptors present higher affinity and modified subunit composition in spinal motor neurons from a genetic model of amyotrophic lateral sclerosis
Irene Carunchio et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2008)
Ammonium tetrathiomolybdate delays onset, prolongs survival, and slows progression of disease in a mouse model for amyotrophic lateral sclerosis
Eiichi Tokuda et al.
EXPERIMENTAL NEUROLOGY (2008)
Treatment with edaravone, initiated at symptom onset, slows motor decline and decreases SOD1 deposition in ALS mice
Hidefumi Ito et al.
EXPERIMENTAL NEUROLOGY (2008)
A dopamine receptor antagonist L-745,870 suppresses microglia activation in spinal cord and mitigates the progression in ALS model mice
Kazunori Tanaka et al.
EXPERIMENTAL NEUROLOGY (2008)
Molecular dissection of ALS-associated toxicity of SOD1 in transgenic mice using an exon-fusion approach
Deng Han-Xiang et al.
HUMAN MOLECULAR GENETICS (2008)
Biological effects of CCS in the absence of SOD1 enzyme activation: implications for disease in a mouse model for ALS
Jody B. Proescher et al.
HUMAN MOLECULAR GENETICS (2008)
A limited role for disulfide cross-linking in the aggregation of mutant SOD1 linked to familial amyotrophic lateral sclerosis
Celeste M. Karch et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
A Drosophila model for amyotrophic lateral sclerosis reveals motor neuron damage by human SOD1
Melanie R. Watson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Expression of mutant SOD1G93A in astrocytes induces functional deficits in motoneuron mitochondria
Lynsey G. Bilsland et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Late stage treatment with arimoclomol delays disease progression and prevents protein aggregation in the SOD1G93A mouse model of ALS
Bernadett Kalmar et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Motor neuron regeneration in adult zebrafish
Michell M. Reimer et al.
JOURNAL OF NEUROSCIENCE (2008)
Neuron-specific expression of mutant superoxide dismutase is sufficient to induce amyotrophic lateral sclerosis in transgenic mice
Dick Jaarsma et al.
JOURNAL OF NEUROSCIENCE (2008)
Ablation of Proliferating Microglia Does Not Affect Motor Neuron Degeneration in Amyotrophic Lateral Sclerosis Caused by Mutant Superoxide Dismutase
Genevieve Gowing et al.
JOURNAL OF NEUROSCIENCE (2008)
Neonatal Neuronal Circuitry Shows Hyperexcitable Disturbance in a Mouse Model of the Adult-Onset Neurodegenerative Disease Amyotrophic Lateral Sclerosis
Brigitte van Zundert et al.
JOURNAL OF NEUROSCIENCE (2008)
Mitochondrial dysfunction in S0D1G93A-bearing astrocytes promotes motor neuron degeneration:: Prevention by mitochondrial-targeted antioxidants
Patricia Cassina et al.
JOURNAL OF NEUROSCIENCE (2008)
Nrf2 Activation in Astrocytes Protects against Neurodegeneration in Mouse Models of Familial Amyotrophic Lateral Sclerosis
Marcelo R. Vargas et al.
JOURNAL OF NEUROSCIENCE (2008)
Effects of estrogen on lifespan and motor functions in female hSOD1 G93A transgenic mice
Chan-Il Choi et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2008)
TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology:: a genetic and histopathological analysis
Vivianna M. Van Deerlin et al.
LANCET NEUROLOGY (2008)
Systemic AAV6 delivery mediating RNA interference against SOD1: Neuromuscular transduction does not alter disease progression in fALS mice
Chris Towne et al.
MOLECULAR THERAPY (2008)
Arimoclomol at dosages up to 300 mg/day is well tolerated and safe in amyotrophic lateral sclerosis
Merit E. Cudkowicz et al.
MUSCLE & NERVE (2008)
TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis
Edor Kabashi et al.
NATURE GENETICS (2008)
Focal transplantation-based astrocyte replacement is neuroprotective in a model of motor neuron disease
Angelo C. Lepore et al.
NATURE NEUROSCIENCE (2008)
Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis
Koji Yamanaka et al.
NATURE NEUROSCIENCE (2008)
Protective effects of heat shock protein 27 in a model of ALS occur in the early stages of disease progression
Paul S. Sharp et al.
NEUROBIOLOGY OF DISEASE (2008)
Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis
A. Vercelli et al.
NEUROBIOLOGY OF DISEASE (2008)
Clinical, electrophysiologic, and pathologic evidence for sensory abnormalities in ALS
Georgios Amoiridis et al.
NEUROLOGY (2008)
Subcutaneous IGF-1 is not beneficial in 2-year ALS trial
E. J. Sorenson et al.
NEUROLOGY (2008)
NEURON-SPECIFIC OVEREXPRESSION OF THE CO-CHAPERONE BCL-2-ASSOCIATED ATHANOGENE-1 IN SUPEROXIDE DISMUTASE 1G93A-TRANSGENIC MICE
G. Rohde et al.
NEUROSCIENCE (2008)
Caspases in apoptosis and beyond
J. Li et al.
ONCOGENE (2008)
Messenger RNA Oxidation Occurs Early in Disease Pathogenesis and Promotes Motor Neuron Degeneration in ALS
Yueming Chang et al.
PLOS ONE (2008)
Lithium delays progression of amyotrophic lateral sclerosis
Francesco Fornai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS
Isaac M. Chiu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS
Bradley J. Turner et al.
PROGRESS IN NEUROBIOLOGY (2008)
TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis
Jemeen Sreedharan et al.
SCIENCE (2008)
Up-regulation of insulin-like growth factor-II receptor in reactive astrocytes in the spinal cord of amyotrophic lateral sclerosis transgenic rats
Byambasuren Dagvajantsan et al.
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Clinical, electrophysiologic, and pathologic evidence for sensory abnormalities in ALS
M. Hammad et al.
NEUROLOGY (2007)
Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial
Paul H. Gordon et al.
LANCET NEUROLOGY (2007)
Redox modifier genes in amyotrophic lateral sclerosis in mice
Jennifer J. Marden et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Overexpression of mutant superoxide dismutase 1 causes a motor axonopathy in the zebrafish
Robin Lemmens et al.
HUMAN MOLECULAR GENETICS (2007)
Identification and characterization of cholest-4-en-3-one, oxime (TRO19622), a novel drug candidate for amyotrophic lateral sclerosis
Thierry Bordet et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Molecular mechanisms of spinal muscular atrophy
Charlotte J. Sumner
JOURNAL OF CHILD NEUROLOGY (2007)
Amyotrophic lateral sclerosis-associated copper/zinc superoxide dismutase mutations preferentially reduce the repulsive charge of the proteins
Erik Sandelin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Implications of ALS focality - Rostral-caudal distribution of lower motor neuron loss postmortem
John Ravits et al.
NEUROLOGY (2007)
Inhibition of p38 mitogen activated protein kinase activation and mutant SOD1 G93A-induced motor neuron death
Maarten Dewil et al.
NEUROBIOLOGY OF DISEASE (2007)
Lost in translation: Treatment trials in the SOD1 mouse and in human ALS
Michael Benatar
NEUROBIOLOGY OF DISEASE (2007)
Gene transfer demonstrates that muscle is not a primary target for non-cell-autonomous toxicity in familial amyotrophic lateral sclerosis
Timothy M. Miller et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Manofluorographic evaluation of swallowing in amyotrophic lateral sclerosis and its relationship with clinical evaluation of swallowing
Ann Goeleven et al.
AMYOTROPHIC LATERAL SCLEROSIS (2006)
Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis
Manuela Neumann et al.
SCIENCE (2006)
ALS:: A disease of motor neurons and their nonneuronal neighbors
Sverine Boillee et al.
NEURON (2006)
Alzheimer disease: progress or profit?
Claire Mount et al.
NATURE MEDICINE (2006)
Minocycline neuroprotects, reduces microgliosis, and inhibits caspase protease expression early after spinal cord injury
Barry W. Festoff et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Conversion to the amyotrophic lateral sclerosis phenotype is associated with intermolecular linked insoluble aggregates of SOD1 in mitochondria
HX Deng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF
S Pun et al.
NATURE NEUROSCIENCE (2006)
Disulphide-reduced superoxide dismutase-1 in CNS of transgenic amyotrophic lateral sclerosis models
PA Jonsson et al.
BRAIN (2006)
Swelling and vacuolisation of mitochondria in transgenic SODI-ALS mice: A consequence of supranormal SOD1 expression?
D Jaarsma
MITOCHONDRION (2006)
Amyotrophic lateral sclerosis associated with mutations in the CuZn superoxide dismutase gene
Peter M. Andersen
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2006)
Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis
M Urushitani et al.
NATURE NEUROSCIENCE (2006)
Therapeutic benefit of intrathecal injection of insulin-like growth factor-1 in a mouse model of Amyotrophic Lateral Sclerosis
I Nagano et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2005)
Manganese porphyrin given at symptom onset markedly extends survival of ALS mice
JP Crow et al.
ANNALS OF NEUROLOGY (2005)
A dopamine D4 receptor antagonist attenuates ischemia-induced neuronal cell damage via upregulation of neuronal apoptosis inhibitory protein
Y Okada et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2005)
Neuroprotective effect of oxidized galectin-1 in a transgenic mouse model of amyotrophic lateral sclerosis
R Chang-Hong et al.
EXPERIMENTAL NEUROLOGY (2005)
Sodium phenylbutyrate prolongs survival and regulates expression of anti-apoptotic genes in transgenic amyotrophic lateral sclerosis mice
H Ryu et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Mouse motor neuron disease caused by truncated SOD1 with or without C-terminal modification
Y Watanabe et al.
MOLECULAR BRAIN RESEARCH (2005)
Overexpression of copper/zinc superoxide dismutase decreases ischemia-like astrocyte injury
H Wang et al.
FREE RADICAL BIOLOGY AND MEDICINE (2005)
β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression
JD Rothstein et al.
NATURE (2005)
Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS
E Storkebaum et al.
NATURE NEUROSCIENCE (2005)
Treatment with arimoclomol, a coinducer of heat shock proteins, delays disease progression in ALS mice
D Kieran et al.
NATURE MEDICINE (2004)
Minute quantities of misfolded mutant superoxide dismutase-1 cause amyotrophic lateral sclerosis
PA Jonsson et al.
BRAIN (2004)
A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis
AL Nishimura et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2004)
Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease
B Ravikumar et al.
NATURE GENETICS (2004)
DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4)
YZ Chen et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2004)
Message and protein-level elevation of tumor necrosis factor α(TNFα) and TNFα-modulating cytokines in spinal cords of the G93A-SOD1 mouse model for amyotrophic lateral sclerosis
K Hensley et al.
NEUROBIOLOGY OF DISEASE (2003)
Mutant SOD1 linked to familial amyotrophic lateral sclerosis, but not wild-type SOD1, induces ER stress in COS7 cells and transgenic mice
S Tobisawa et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Mutant dynactin in motor neuron disease
I Puls et al.
NATURE GENETICS (2003)
Copper-binding-site-null SOD1 causes ALS in transgenic mice: aggregates of non-native SOD1 delineate a common feature
J Wang et al.
HUMAN MOLECULAR GENETICS (2003)
Mutated human SOD1 causes dysfunction of oxidative phosphorylation in mitochondria of transgenic mice
M Mattiazzi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Minocycline slows disease progression in a mouse model of arnyotrophic lateral sclerosis
J Kriz et al.
NEUROBIOLOGY OF DISEASE (2002)
Fibrillar inclusions and motor neuron degeneration in transgenic mice expressing superoxide dismutase 1 with a disrupted copper-binding site
J Wang et al.
NEUROBIOLOGY OF DISEASE (2002)
Minocycline delays disease onset and mortality in a transgenic model of ALS
L Van Den Bosch et al.
NEUROREPORT (2002)
A quantitative histochemical assay for activities of mitochondrial electron transport chain complexes in mouse spinal cord sections
CW Jung et al.
JOURNAL OF NEUROSCIENCE METHODS (2002)
Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS)
DS Howland et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells
M Göttlicher et al.
EMBO JOURNAL (2001)
The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis
Y Yang et al.
NATURE GENETICS (2001)
A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2
S Hadano et al.
NATURE GENETICS (2001)
Effects of riluzole on N-methyl-D-aspartate-induced tyrosine phosphorylation in the rat hippocampus
A Peyclit et al.
BRAIN RESEARCH (2001)
Formation of high molecular weight complexes of mutant Cu,Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis
JA Johnston et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
A phase I/II trial of recombinant methionyl human brain derived neurotrophic factor administered by intrathecal infusion to patients with amyotrophic lateral sclerosis
G Ochs et al.
AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS (2000)
Share Paper
